North Dartmouth, MANCT07646587Now EnrollingIRB Ready

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trial in North Dartmouth, MA

Access cutting-edge copd (chronic obstructive pulmonary disease) treatment through this clinical trial at a research site in North Dartmouth. Study-provided care at no cost to qualified participants.

Sponsored by Windward Bio

Quick Self-Assessment

See if you qualify for this North Dartmouth location

Preparing your pre-screening questions…

Expert Care in North Dartmouth

Access copd (chronic obstructive pulmonary disease) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related copd (chronic obstructive pulmonary disease) treatment provided free

Apply for This North Dartmouth Location

Check if you qualify for this copd (chronic obstructive pulmonary disease) clinical trial in North Dartmouth, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to North Dartmouth

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit North Dartmouth site if eligible
  4. 4Begin participation

About This COPD (Chronic Obstructive Pulmonary Disease) Study in North Dartmouth

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COPD control and symptoms. The study will test how doses of WIN378 are handled by the body (pharmacokinetics) and assess the safety of the medicine and markers of COPD inflammation in exhaled breath and blood, lung function and COPD control (pharmacodynamics)

Sponsor: Windward Bio

Who Can Participate

Inclusion Criteria

Adults aged 40 to 80 years
Post-BD spirometry at screening FEV1/FVC \< 0.70 and FEV1 30-80% predicted
On stable triple inhaled therapy (ICS/LABA/LAMA) for ≥ 3 months
Former smoker (≥ 10 pack-year history) and abstinence from smoking for ≥ 6 months
Elevated eosinophil count
Weight/BMI within allowed range

Exclusion Criteria

Clinically significant pulmonary disease other than chronic obstructive pulmonary disease (COPD)
Clinically significant comorbid medical conditions or infections that, in the investigator's judgment, could affect participant safety or interfere with study conduct
Clinically significant cardiovascular disease
Recent respiratory infection or COPD exacerbation
Exposure to approved or experimental biologic therapies for COPD with less than 5 half-life washout period
Pregnancy or breastfeeding
Smoking or diagnosed substance use disorder
Any condition or circumstance that, in the investigator's opinion, would make participation unsafe or compromise study integrity

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in North Dartmouth?

Yes, this clinical trial (NCT07646587) has an active research site in North Dartmouth, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

COPD (Chronic Obstructive Pulmonary Disease) Treatment Options in North Dartmouth, MA

If you're searching for copd (chronic obstructive pulmonary disease) treatment options in North Dartmouth, MA, this clinical trial (NCT07646587) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our North Dartmouth research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd (chronic obstructive pulmonary disease) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all copd (chronic obstructive pulmonary disease) clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in North Dartmouth, MA

See all parkinsons disease clinical trials recruiting in North Dartmouth — not just this study.

Browse Parkinsons Disease Trials in North Dartmouth

Ready to Join in North Dartmouth?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · North Dartmouth, MA